Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus
- PMID: 20190974
- PMCID: PMC2777288
Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus
Abstract
This study determined the efficacy of a 5-day extended therapy with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Chronically infected cows selected from 14 dairy herds in the St-Hyacinthe region, Québec were randomly allocated to a group of 31 cows treated for 5 consecutive days with 200 mg of cephapirin per quarter BID or a group of 30 untreated control cows. Bacteriological cure was determined by 3 negative bacterial cultures at 10, 24, and 31 days after treatment. The cow cure rates were 25.8% (8/31) in the treated cows and 3.3% (1/30) in the control group (P = 0.013). The quarter cure rates at first sampling post-treatment were 77.6% (38/49) and 18% (9/50) in the treated and the control groups, respectively (P < 0.0001). A 5-day extended therapy with cephapirin is effective in treating cows chronically infected with S. aureus.
Efficacité d’un programme de thérapie prolongée de 5 jours à la céphapirine sodique durant la lactation chez les vaches laitières chroniquement infectées par Staphylococcus aureus. L’étude a déterminé l’efficacité d’une thérapie prolongée de 5 jours à la céphapirine sodique chez des vaches laitières chroniquement infectées par Staphylococcus aureus. Les vaches chroniquement infectées choisies de 14 troupeaux laitiers dans la région de Saint-Hyachinthe, au Québec, ont été assignées au hasard à un groupe de 31 vaches traitées pendant 5 jours consécutifs avec 200 mg de céphapirine par quartier bid ou à un groupe témoin de 30 vaches non traitées. La guérison bactériologique a été déterminée par 3 cultures bactériennes négatives 10, 24 et 31 jours après le traitement. Les taux de guérison des vaches étaient de 25,8 % (8/31) chez les vaches traitées et de 3,3 % (1/30) dans le groupe témoin (P = 0,013). Les taux de guérison des quartiers au premier échantillon après le traitement étaient de 77,6 % (38/49) et de 18 % (9/50) dans le groupe traité et le groupe témoin, respectivement (P < 0,0001). Une thérapie prolongée de 5 jours à la céphapirine est efficace pour traiter les vaches chroniquement infectées par S. aureus.
(Traduit par Isabelle Vallières)
Similar articles
-
Bacterial cure and somatic cell count response of dairy cows with a positive California Mastitis Test at calving to therapy with cephapirin sodium.Vet Ther. 2002 Winter;3(4):381-6. Vet Ther. 2002. PMID: 12584674 Clinical Trial.
-
Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.Vet Ther. 2002 Winter;3(4):373-80. Vet Ther. 2002. PMID: 12584673 Clinical Trial.
-
Pharmacokinetics in foremilk and antimicrobial activity of cephapirin following intramammary administration in healthy and Staphylococcus aureus-infected cows.N Z Vet J. 2014 May;62(3):146-51. doi: 10.1080/00480169.2013.865295. Epub 2014 Jan 9. N Z Vet J. 2014. PMID: 24224523
-
Comparison of tilmicosin and cephapirin as therapeutics for Staphylococcus aureus mastitis at dry-off.J Dairy Sci. 1999 Apr;82(4):696-703. doi: 10.3168/jds.S0022-0302(99)75286-0. J Dairy Sci. 1999. PMID: 10212455
-
Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis.J Dairy Sci. 2006 Jun;89(6):1877-95. doi: 10.3168/jds.S0022-0302(06)72256-1. J Dairy Sci. 2006. PMID: 16702252 Review.
Cited by
-
Enhanced Treatment Effects of Tilmicosin Against Staphylococcus aureus Cow Mastitis by Self-Assembly Sodium Alginate-Chitosan Nanogel.Pharmaceutics. 2019 Oct 12;11(10):524. doi: 10.3390/pharmaceutics11100524. Pharmaceutics. 2019. PMID: 31614726 Free PMC article.
-
Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial.Can J Vet Res. 2014 Jan;78(1):31-7. Can J Vet Res. 2014. PMID: 24396178 Free PMC article. Clinical Trial.
-
Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extended intramammary administration in healthy and infected cows.PLoS One. 2017 Nov 2;12(11):e0187261. doi: 10.1371/journal.pone.0187261. eCollection 2017. PLoS One. 2017. PMID: 29095869 Free PMC article.
-
Staphylococcal mastitis in dairy cows.Front Vet Sci. 2024 May 28;11:1356259. doi: 10.3389/fvets.2024.1356259. eCollection 2024. Front Vet Sci. 2024. PMID: 38863450 Free PMC article. Review.
-
In vitro antibiotic susceptibility and biofilm production of Staphylococcus aureus isolates recovered from bovine intramammary infections that persisted or not following extended therapies with cephapirin, pirlimycin or ceftiofur.Vet Res. 2017 Sep 21;48(1):56. doi: 10.1186/s13567-017-0463-0. Vet Res. 2017. PMID: 28934980 Free PMC article.
References
-
- Bradley AJ, Leach KA, Breen JE, Green MJ. Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales. Vet Rec. 2007;160:253–258. - PubMed
-
- Olde Riekerink RGM, Barkema HW, Kelton DF, Scholl DT. Incidence rate of clinical mastitis on Canadian dairy farms. J Dairy Sci. 2008;91:1366–1377. - PubMed
-
- Barkema HW, Schukken YH, Zadoks RN. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci. 2006;89:1877–1895. - PubMed
-
- Shpigel NY, Kass PH, Saran A. A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows. J Vet Med A. 2006;53:418–422. - PubMed
-
- Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res. 2003;34:475–491. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical